Improving Patient Memory for Treatment for Mild Cognitive Impairment
Launched by UNIVERSITY OF CALIFORNIA, BERKELEY · Dec 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different types of memory support can help people with mild cognitive impairment (MCI) compared to those without MCI. The goal is to find out which memory aids are most effective for older adults who may be experiencing memory issues along with sleep problems. Researchers are looking for participants who are 60 years or older, speak English, and have specific scores on a memory test. Participants should also have a computer and internet access to join weekly sessions.
If you or someone you know might be interested, it's important to note that participants should not have any serious ongoing mental or physical illnesses and should not have worked night shifts regularly in the past few months. Throughout the study, participants will take part in assessments and treatments aimed at improving memory and sleep. This trial could be a valuable opportunity for those dealing with memory challenges to find new ways to support their cognitive health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants 60 years and older will be recruited.
- • 2. Fluent in English.
- • 3. Experiencing some difficulties relating to sleep and circadian functioning and (d) a score of 19-25 on the Montreal Cognitive Assessment (for the MCI group) and score 26-30 on the Montreal Cognitive Assessment (for the non-MCI group) (e) Have a computer to use and an internet connection and (f) be able to attend sessions weekly and on the same day each week.
- Exclusion criteria:
- • 1. Presence of an active and progressive mental or physical illness or neurological degenerative disease;
- • 2. Night shift work \>2 nights per week in the past 3 months;
- • 3. Not able and willing to participate in and/or complete the assessments and participate in the treatment.
About University Of California, Berkeley
The University of California, Berkeley, a leading research institution renowned for its commitment to scientific innovation and academic excellence, serves as a prominent sponsor of clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a robust infrastructure for interdisciplinary collaboration, UC Berkeley leverages its distinguished faculty, cutting-edge laboratories, and extensive resources to conduct research that addresses critical health challenges. The university is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical investigations, ultimately contributing to the translation of scientific discoveries into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berkeley, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials